Kinesin-1 consists of two heavy chains (KHCs), also called KIF5s, and two light chains (KLCs) that form a heterotetrameric complex. Here, we demonstrate the binding of a neuronal KHC, KIF5A, to the carboxyl (C)-terminal tail region of Fig4 (also known as Sac3), a phosphatase that removes the 5-phosphate from phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2). Fig4 bound to the C-terminal region of KIF5A but not to other KHCs (KIF5B and KIF5C) and KLC1 in yeast two-hybrid assays.
Introduction
Compared with other cells, neurons with long neurites have a well-developed transport system. Intracellular transport mechanism is controlled by microtubule-dependent motor proteins [5] . Kinesin-1 is a motor protein that utilizes ATP hydrolysis to drive the intracellular transport along microtubules and has been reported to transport various types of cargoes, including organelles, synaptic vesicle precursors, neurotransmitter receptors, cell signaling molecules, and mRNAs in the neurons [5, 10] . Kinesin-1 is a heterotetramer composed of two kinesin heavy chains (KHCs, also called KIF5s) and two kinesin light chains (KLCs) [10] . KHC has a motor domain that hydrolyzes ATP. KLC is involved in modulation of KHC motor activity [5] . KHC has specific cargo-binding regions and KLC-binding domains in its carboxyl (C)-terminus [11] . There are three KHCs (KIF5A, KIF5B, and KIF5C), which are encoded by different genes and possess a similar motor domain containing a microtubule-binding motif in the amino (N)-terminus and a different carboxyl (C)-terminus. KIF5B appears to be ubiquitously expressed, whereas KIF5A and KIF5C appear to be expressed in neuron [14] .
Using the many new methods makes it possible to identify the binding proteins of kinesin-1 [11] . KIF5s-binding proteins include glutamate receptor-interacting protein 1 (GRIP1) [21] , mRNA/protein (mRNP) complex [13] , SNAP25 [6] , syntabulin [22] , β-dystrobrevin [11] , DISC1 [11] , and GABARAP [18] . The proteins that bind to the tetratricopeptide repeat (TRP) domain of KLC have also been identified. These include c-jun NH2-terminal kinase (JNK)-interacting proteins (JIPs) [4] and amyloid-β precursor protein (APP) [17] .
To investigate in vivo functions of KIF5s, kif5 knockout (KO) mice were generated. Kif5b-KO mice are embryonic lethal and show abnormal localization of mitochondria [24] .
Kif5c-KO mice are normal in their appearance but show a smaller brain size [14] . Kif5a-KO mice are neonatal lethal but show no apparent histological abnormalities in their brains except that the nuclei and cell bodies of spinal cord motor neurons appear to be larger than the wild-type (WT) [25] .
More than 75% of conditional Kif5a-KO mice undergo seizures and die within 3 weeks [25] . KIF5A has been suggested to be important for the viability of neurons [25] . KIF5A mutations have been found to cause SPG10, a rare form of hereditary spastic paraplegia (SPG) in human [19] . However, despite increasing number of reports for cargoes carried by kinesin-1, KIF5A-specific cargo or binding protein(s) capable of explaining these phenotypes are still unknown. Thus, we searched for KIF5A-specific binding partners that bind to the C-terminal region of KIF5A and found an interaction with Fig4, a phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2) 5-phosphatase [12] . The KIF5A and Fig4 interaction suggests The Matchmaker LexA two-hybrid system was used for screening according to the manufacturer's manual (Clontech). In brief, yeast strain EGY48 carrying the p8op-lacZ reporter plasmid was transformed with pLexA-KIF5A. The yeast cells were subsequently transformed with the mouse brain cDNA library and grown on synthetic dextrose (SD) plates supplemented with glucose but with no histidine, tryptophan, or uracil (SD/-His/-Trp/-Ura). The selection of positive clones was performed on an SD/-His/-Trp/-Ura/-Leu plate containing galactose, raffinose, X-gal, and BU salts. Plasmids from positive clones were analyzed by digestion with EcoRI and XhoI. Unique inserts were sequenced and protein sequence analysis was performed with the BLAST algorithm at the National Center for Biotechnology Information (NCBI).
Sequence-verified clones were tested again for interaction with the bait in yeast by retransformation.
β-Galactosidase activity in liquid cultures of yeast
The β-galactosidase activity of yeast was assayed as described previously [16, 23] . Mid-log phase yeast cells were collected and permeabilized with 0.1% sodium dodecyl sulfate (SDS) and chloroform. An excess amount of o-nitrophenyl-β-D-galactoside (ONPG) was added to yeast lysate. The mixture was incubated at 30°C and then the reaction was stopped by increasing pH to 11 by the addition of 1 M Na2CO3. The formation of the reaction product, o-nitrophenol, was determined by measuring absorbance at 420 nm on a spectrophotometer and normalizing for the reaction time. The units of enzyme activity were calculated by the following equation: units=1000×[(OD420-1.75×OD550)]/(reaction time×culture volume×OD600). All experiments were independently performed at least three times [2] .
Glutathione S-transferase (GST) pull-down assays
The cDNA fragments of Fig4 were cloned into pET41a. The recombinant GST-Fig4 fusion proteins were expressed in bacterial strain BL21 GOLD (Stratagene, La Jolla CA, USA) after induction with 0.5 mM isopropyl thio-β-D-galactopyranoside (IPTG) for 2 hr. The fusion proteins were purified using glutathione-agarose beads (Sigma-Aldrich) according to the manufacturer's protocol. The mouse brain S2 fraction was incubated overnight at 4°C with the GST fusion protein-coupled glutathione beads. The beads were pelleted by centrifugation, washed three times with the extraction buffer (1% Triton X-100 in PBS containing 10 μg/ml each aprotinin, leupeptin, and pepstatin and 1 μM phenylmethanesulfonyl fluoride), and once with PBS. The bound proteins were eluted from the glutathione beads with 100 μl of Laemmli ' s loading buffer. The pulled-down proteins were analyzed by immunoblotting with anti-KIF5A, anti-KIF5B, anti-KIF5C, and anti-KLC1 antibodies [14] . Co-immunoprecipitation Mouse brains were homogenized in ice-cold homogenization buffer (0.32 M sucrose, 4 mM HEPES, pH 7.3) supplemented with protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA). For immunoprecipitation, mouse brain lysate was diluted in the same volume of 2X binding buffer (50 mM HEPES, 200 mM KCl, 0.2% Triton X-100, pH 7.0) and incubated with anti-KIF5A antibody, anti-KIF5B antibody, anti-KIF5C antibody [14] , or preimmune rabbit serum overnight at 4°C, followed by precipitation with protein-A Sepharose (Amersham Pharmacia, Piscataway, NJ, USA). 
Results
Identification of KIF5A interacting protein by yeast two-hybrid screening KIF5A has the C-terminal region of 73 amino acids that shows no homology with KIF5B or KIF5C [14] . To identify KIF5A interacting proteins, we screened a mouse brain cDNA library by yeast two-hybrid system using the C-terminal 73 amino acids (aa 955-1027) of KIF5A as bait. (Fig. 1A) . Fig4 was isolated as a vacuolar-associated PtdIns(3,5)P2 5-phosphatase related to the suppressor of actin (Sac) 1 PtdInsP phosphatase [9, 20] . To determine the minimal binding domain of Fig4 that is required for the interaction with KIF5A, we constructed several deletion mutants of Fig4. Yeast two-hybrid assays showed that the minimal domain required for binding was located in the C-terminal tail region of Fig4 (Fig. 1B) . Next, we determined the minimal binding domain of KIF5A. KIF5A is composed of motor domain, neck domain, stalk domain, and KLC binding domain [14] . We constructed several deletion mutants of KIF5A and tested for the interaction with Fig4. The interaction with Fig4 was dependent on the C-terminal region of KIF5A (Fig. 1C) . Together, these results show that the interaction between KIF5A and Fig4 is mediated through their C-terminal regions.
KIF5A consists of 1027 amino acids and shows high sequence homology to KIF5B or KIF5C (60% identical) [14] . Next we analyzed whether Fig4 interacts with KIF5B, KIF5C, and KLC1 subunits of kinesin-1. As shown in Fig.  2A , there was no detectable binding of Fig4 with KIF5B, KIF5C, and KLC1. A quantitative β-galactosidase assay showed that Fig4 directly bound to KIF5A but not to other KIF5s and KLC1 (Fig. 2B ). This result was not surprising in view of the fact that KIF5A, KIF5B, and KIF5C have no homology in their C-terminal regions [14] . These data indicate that the interaction of KIF5A with Fig4 is specific and the C-terminal 73 amino acids of KIF5A were sufficient for the interaction. Kinesin-1 is a heterotetramer made of two KIF5s and two KLCs [10, 14] . Previous immunoprecipitation experiments revealed that heterodimers as well as homodimers of KIF5s may constitute kinesin-1. KIF5A can form heterodimers with KIF5B or KIF5C [14] . Therefore, we next determined whether Fig4 precipitates not only KIF5A but also other kinesin-1 subunits at the protein level using GST pull-down experiments. Recombinant GST-Fig4 fusion proteins were expressed in E. coli. The purified GST fusion proteins were allowed to interact with mouse brain lysates. Immunoblotting analyses revealed that KIF5A interacted with GST-Fig4, but not to GST-Fig4-Sac1 domain. KIF5B, KIF5C, and KLC1, which interact with the KIF5A [14] , were also efficiently precipitated by GST- Fig4 (Fig. 3A) . This result indicates that Fig4 interacts with kinesin-1 complex.
The association of Fig4 with kinesin-1 was further examined by co-immunoprecipitation assay. Lysates from mouse brain were incubated with anti-KIF5A antibody, anti-KIF5B antibody, or anti-KIF5C antibody. Protein A-Separose beads selectively precipitated the immuno-complexes, which were then subsequently separated by SDS-PAGE and immuno-blotted with anti-Fig4 antibody. As shown in Fig. 3B Lipids including phosphoinositides are implicated in signal transduction, organelle trafficking, and intracellular transport [12] . PtdIns(3,5)P2 is one of seven phosphoinositides and a low-abundant species that is mainly found in endolysosomes [12, 20] . PtdIns(3,5)P2 dysfunction is implicated in some human neurodegenerative diseases such as Charcot-Marie-Tooth Type 4J (CMT4J) disease and amyotrophic lateral sclerosis [7, 15] . Patients with CMT4J, which is caused by loss-of-function mutation of FIG4 gene, exhibit neurodegeneration in the central and peripheral nervous systems, affecting sensory and motor neurons [7, 26] . CMT4J cells possess enlarged endolysosomes and lysosomes [7] . It is unclear how Fig4 deficiency causes abnormal endolysosomes and lysosomes. In mammals, Fig4 mainly localizes to lysosomes [12, 20] . PtdIns (3, 5) P2 is known to relate to the endolysosome morphology, trafficking, and acidification [12] , which, therefore, could be modulated by Fig4-mediated PtdIns(3,5)P2 turnover. Fig4 binds directly to Vac14, which is necessary for PtdIns(3,5)P2 synthesis [3, 8, 12] . Interestingly, Fig4-Vac14 complex interacts with PtdIns(3)P5-kinase Fab1. Fab1 localizes to endolysosomes or lysosomes [8] . Vac14 is necessary for the interaction between Fig4 and Fab1, indicating that Vac14 is an adaptor protein for formation of Fig4-Vac14-Fab1 complex [1] . The Fig4-Vac14-Fab1 complex may regulate PtdIns(3,5)P2 synthesis and turn over on endolysosomes or lysosomes.
As described in this study, KIF5A directly interacted with Fig4. Although we did not identify Fig4-associated cargo, this data suggested that the interaction between KIF5A and Fig4 may link kinesin-1 to endolysosomes or lysosomes through Fig4-Vac14-Fab1 complex. In conclusion, we favor the model that Fig4, involved in regulation of PtdIns(3,5)P2, may also play a role as an adaptor protein in the intracellular transport of endolysosomes or lysosomes by kinesin-1.
